Attached files

file filename
10-Q - FORM 10-Q - GALECTIN THERAPEUTICS INCd402747d10q.htm
XML - IDEA: XBRL DOCUMENT - GALECTIN THERAPEUTICS INCR33.htm
EX-31.2 - CERTIFICATION PURSUANT TO RULE 13A-14(A) - GALECTIN THERAPEUTICS INCd402747dex312.htm
EX-32.1 - CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 - GALECTIN THERAPEUTICS INCd402747dex321.htm
EX-10.3 - EMPLOYMENT AGREEMENT - GALECTIN THERAPEUTICS INCd402747dex103.htm
EX-31.1 - CERTIFICATION PURSUANT TO RULE 13A-14(A) - GALECTIN THERAPEUTICS INCd402747dex311.htm
EXCEL - IDEA: XBRL DOCUMENT - GALECTIN THERAPEUTICS INCFinancial_Report.xls
XML - IDEA: XBRL DOCUMENT - GALECTIN THERAPEUTICS INCR6.htm
XML - IDEA: XBRL DOCUMENT - GALECTIN THERAPEUTICS INCR9.htm
XML - IDEA: XBRL DOCUMENT - GALECTIN THERAPEUTICS INCR2.htm
XML - IDEA: XBRL DOCUMENT - GALECTIN THERAPEUTICS INCR5.htm
XML - IDEA: XBRL DOCUMENT - GALECTIN THERAPEUTICS INCR1.htm
XML - IDEA: XBRL DOCUMENT - GALECTIN THERAPEUTICS INCR7.htm
XML - IDEA: XBRL DOCUMENT - GALECTIN THERAPEUTICS INCR8.htm
XML - IDEA: XBRL DOCUMENT - GALECTIN THERAPEUTICS INCR4.htm
XML - IDEA: XBRL DOCUMENT - GALECTIN THERAPEUTICS INCR21.htm
XML - IDEA: XBRL DOCUMENT - GALECTIN THERAPEUTICS INCR14.htm
XML - IDEA: XBRL DOCUMENT - GALECTIN THERAPEUTICS INCR17.htm
XML - IDEA: XBRL DOCUMENT - GALECTIN THERAPEUTICS INCR23.htm
XML - IDEA: XBRL DOCUMENT - GALECTIN THERAPEUTICS INCR29.htm
XML - IDEA: XBRL DOCUMENT - GALECTIN THERAPEUTICS INCR32.htm
XML - IDEA: XBRL DOCUMENT - GALECTIN THERAPEUTICS INCR26.htm
XML - IDEA: XBRL DOCUMENT - GALECTIN THERAPEUTICS INCR18.htm
XML - IDEA: XBRL DOCUMENT - GALECTIN THERAPEUTICS INCR30.htm
XML - IDEA: XBRL DOCUMENT - GALECTIN THERAPEUTICS INCR10.htm
XML - IDEA: XBRL DOCUMENT - GALECTIN THERAPEUTICS INCR24.htm
XML - IDEA: XBRL DOCUMENT - GALECTIN THERAPEUTICS INCR20.htm
XML - IDEA: XBRL DOCUMENT - GALECTIN THERAPEUTICS INCR15.htm
XML - IDEA: XBRL DOCUMENT - GALECTIN THERAPEUTICS INCR28.htm
XML - IDEA: XBRL DOCUMENT - GALECTIN THERAPEUTICS INCR13.htm
XML - IDEA: XBRL DOCUMENT - GALECTIN THERAPEUTICS INCR16.htm
XML - IDEA: XBRL DOCUMENT - GALECTIN THERAPEUTICS INCR19.htm
XML - IDEA: XBRL DOCUMENT - GALECTIN THERAPEUTICS INCR27.htm
XML - IDEA: XBRL DOCUMENT - GALECTIN THERAPEUTICS INCR12.htm
XML - IDEA: XBRL DOCUMENT - GALECTIN THERAPEUTICS INCR11.htm
XML - IDEA: XBRL DOCUMENT - GALECTIN THERAPEUTICS INCR25.htm
XML - IDEA: XBRL DOCUMENT - GALECTIN THERAPEUTICS INCR31.htm
XML - IDEA: XBRL DOCUMENT - GALECTIN THERAPEUTICS INCR22.htm
EX-32.2 - CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 - GALECTIN THERAPEUTICS INCd402747dex322.htm
v2.4.0.6
Condensed Consolidated Balance Sheets (Parenthetical) (USD $)
Sep. 30, 2012
Dec. 31, 2011
Undesignated stock, par value $ 0.01 $ 0.01
Undesignated stock, shares authorized 20,000,000 20,000,000
Undesignated stock, designated 8,001,000 8,001,000
Series A 12% convertible preferred stock, shares authorized 5,000,000 5,000,000
Series A 12% convertible preferred stock, issued 1,562,500 1,562,500
Series A 12% convertible preferred stock, outstanding 1,562,500 1,562,500
Common stock, par value $ 0.001 $ 0.001
Common stock, shares authorized 50,000,000 50,000,000
Common stock, issued 15,966,437 12,919,538
Common stock, outstanding 15,966,437 12,919,538
Series B-1 12% redeemable convertible preferred stock
   
Convertible preferred stock, shares authorized 900,000 900,000
Convertible preferred stock, issued 900,000 900,000
Convertible preferred stock, outstanding 900,000 900,000
Convertible preferred stock, redemption value $ 1,800,000  
Convertible preferred stock, liquidation value 1,800,000  
Series B-2 12% redeemable convertible preferred stock
   
Convertible preferred stock, shares authorized 2,100,000 2,100,000
Convertible preferred stock, issued 2,100,000 2,100,000
Convertible preferred stock, outstanding 2,100,000 2,100,000
Convertible preferred stock, redemption value 4,200,000  
Convertible preferred stock, liquidation value 4,200,000  
Series C super dividend convertible preferred stock
   
Convertible preferred stock, shares authorized 1,000 1,000
Convertible preferred stock, issued 220 220
Convertible preferred stock, outstanding 220 220
Convertible preferred stock, redemption value 4,267,000  
Convertible preferred stock, liquidation value $ 2,200,000